1liu: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /> <applet load="1liu" size="450" color="white" frame="true" align="right" spinBox="true" caption="1liu, resolution 2.72Å" /> '''Human erythrocyte p...
 
Redirecting to 2vgb
Line 1: Line 1:
[[Image:1liu.gif|left|200px]]<br />
#REDIRECT [[2vgb]] This PDB entry is obsolete and replaced by 2vgb
<applet load="1liu" size="450" color="white" frame="true" align="right" spinBox="true"
caption="1liu, resolution 2.72&Aring;" />
'''Human erythrocyte pyruvate kinase'''<br />
 
==Overview==
Deficiency of human erythrocyte isozyme (RPK) is, together with, glucose-6-phosphate dehydrogenase deficiency, the most common cause of the, nonspherocytic hemolytic anemia. To provide a molecular framework to the, disease, we have solved the 2.7 A resolution crystal structure of human, RPK in complex with fructose 1,6-bisphosphate, the allosteric activator, and phosphoglycolate, a substrate analogue, and we have functionally and, structurally characterized eight mutants (G332S, G364D, T384M, D390N, R479H, R486W, R504L, and R532W) found in RPK-deficient patients. The, mutations target distinct regions of RPK structure, including domain, interfaces and catalytic and allosteric sites. The mutations affect to a, different extent thermostability, catalytic efficiency, and regulatory, properties. These studies are the first to correlate the clinical symptoms, with the molecular properties of the mutant enzymes. Mutations greatly, impairing thermostability and/or activity are associated with severe, anemia. Some mutant proteins exhibit moderate changes in the kinetic, parameters, which are sufficient to cause mild to severe anemia, underlining the crucial role of RPK for erythrocyte metabolism. Prediction, of the effects of mutations is difficult because there is no relation, between the nature and location of the replaced amino acid and the type of, molecular perturbation. Characterization of mutant proteins may serve as a, valuable tool to assist with diagnosis and genetic counseling.
 
==Disease==
Known diseases associated with this structure: Pyruvate kinase deficiency OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=609712 609712]]
 
==About this Structure==
1LIU is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with FBP, PGA, K and MN as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Pyruvate_kinase Pyruvate kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.40 2.7.1.40] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1LIU OCA].
 
==Reference==
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia., Valentini G, Chiarelli LR, Fortin R, Dolzan M, Galizzi A, Abraham DJ, Wang C, Bianchi P, Zanella A, Mattevi A, J Biol Chem. 2002 Jun 28;277(26):23807-14. Epub 2002 Apr 17. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=11960989 11960989]
[[Category: Homo sapiens]]
[[Category: Pyruvate kinase]]
[[Category: Single protein]]
[[Category: Abraham, D.J.]]
[[Category: Bianchi, P.]]
[[Category: Chiarelli, L.]]
[[Category: Dolzan, M.]]
[[Category: Fortin, R.]]
[[Category: Galizzi, A.]]
[[Category: Mattevi, A.]]
[[Category: Valentini, G.]]
[[Category: Wang, C.]]
[[Category: Zanella, A.]]
[[Category: FBP]]
[[Category: K]]
[[Category: MN]]
[[Category: PGA]]
[[Category: pyruvate kinase in the active r-state]]
 
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:01:37 2007''

Revision as of 09:16, 25 November 2007

Redirect to:

This PDB entry is obsolete and replaced by 2vgb

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA